WEKO3
アイテム
{"_buckets": {"deposit": "1c2d1812-8647-4570-8593-2869b50a609d"}, "_deposit": {"created_by": 1, "id": "84787", "owners": [1], "pid": {"revision_id": 0, "type": "depid", "value": "84787"}, "status": "published"}, "_oai": {"id": "oai:repo.qst.go.jp:00084787", "sets": ["1"]}, "author_link": ["1043278", "1043284", "1043276", "1043281", "1043274", "1043282", "1043283", "1043279", "1043280", "1043277", "1043275", "1043273"], "item_8_biblio_info_7": {"attribute_name": "書誌情報", "attribute_value_mlt": [{"bibliographicIssueDates": {"bibliographicIssueDate": "2021-11", "bibliographicIssueDateType": "Issued"}, "bibliographicIssueNumber": "11", "bibliographicPageEnd": "5642", "bibliographicPageStart": "5635", "bibliographicVolumeNumber": "41", "bibliographic_titles": [{"bibliographic_title": "Anticancer research"}]}]}, "item_8_description_5": {"attribute_name": "抄録", "attribute_value_mlt": [{"subitem_description": "Background/Aim: To evaluate the outcomes of proton beam therapy (PBT) for early-stage non-small cell lung cancer (NSCLC) in patients with interstitial lung disease (ILD). Patients and Methods: Between 2002 and 2017, 110 patients receiving hypofractionated PBT for cT1-2N0M0 NSCLC were reviewed.\nResults: Of the 110 patients, 17 were diagnosed with ILD. The median follow-up period was 37.8 months. No significant difference in the 1-year cumulative rate of grade ≥2 pneumonitis was observed between patients with and those without ILD (17.6% vs. 14.1%, p=0.708). The lung doses were significantly lower in patients with than in those without ILD among patients without grade ≥2 neumonitis. There were no significant differences in overall survival or local recurrence-free rates according to the presence of ILD. Conclusion: PBT appears to be a feasible and effective treatment for cT1-2N0M0 NSCLC in\npatients with ILD, but the lung dose should be strictly reduced.", "subitem_description_type": "Abstract"}]}, "item_8_publisher_8": {"attribute_name": "出版者", "attribute_value_mlt": [{"subitem_publisher": "International Institute of Anticancer Research"}]}, "item_8_relation_13": {"attribute_name": "PubMed番号", "attribute_value_mlt": [{"subitem_relation_type_id": {"subitem_relation_type_id_text": "34732436", "subitem_relation_type_select": "PMID"}}]}, "item_8_relation_14": {"attribute_name": "DOI", "attribute_value_mlt": [{"subitem_relation_type_id": {"subitem_relation_type_id_text": "10.21873/anticanres.15379", "subitem_relation_type_select": "DOI"}}]}, "item_8_relation_17": {"attribute_name": "関連サイト", "attribute_value_mlt": [{"subitem_relation_type_id": {"subitem_relation_type_id_text": "https://ar.iiarjournals.org/content/41/11/5635", "subitem_relation_type_select": "URI"}}]}, "item_8_source_id_9": {"attribute_name": "ISSN", "attribute_value_mlt": [{"subitem_source_identifier": "0250-7005", "subitem_source_identifier_type": "ISSN"}]}, "item_access_right": {"attribute_name": "アクセス権", "attribute_value_mlt": [{"subitem_access_right": "metadata only access", "subitem_access_right_uri": "http://purl.org/coar/access_right/c_14cb"}]}, "item_creator": {"attribute_name": "著者", "attribute_type": "creator", "attribute_value_mlt": [{"creatorNames": [{"creatorName": "Saito, Takashi"}], "nameIdentifiers": [{"nameIdentifier": "1043273", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Ohnishi, Kayoko"}], "nameIdentifiers": [{"nameIdentifier": "1043274", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Ishikawa, Hitoshi"}], "nameIdentifiers": [{"nameIdentifier": "1043275", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Nakamura, Masatoshi"}], "nameIdentifiers": [{"nameIdentifier": "1043276", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Hoshiai, Sodai"}], "nameIdentifiers": [{"nameIdentifier": "1043277", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Numajiri, Haruko"}], "nameIdentifiers": [{"nameIdentifier": "1043278", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Nemoto Murofushi, Keiko"}], "nameIdentifiers": [{"nameIdentifier": "1043279", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Mizumoto, Masashi"}], "nameIdentifiers": [{"nameIdentifier": "1043280", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Okumura, Toshiyuki"}], "nameIdentifiers": [{"nameIdentifier": "1043281", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Sakurai, Hideyuki"}], "nameIdentifiers": [{"nameIdentifier": "1043282", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Hitoshi, Ishikawa", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "1043283", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Hideyuki, Sakurai", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "1043284", "nameIdentifierScheme": "WEKO"}]}]}, "item_language": {"attribute_name": "言語", "attribute_value_mlt": [{"subitem_language": "eng"}]}, "item_resource_type": {"attribute_name": "資源タイプ", "attribute_value_mlt": [{"resourcetype": "journal article", "resourceuri": "http://purl.org/coar/resource_type/c_6501"}]}, "item_title": "Hypofractionated Proton Beam Therapy for cT1-2N0M0 Non-small Cell Lung Cancer Patients With Interstitial Lung Disease", "item_titles": {"attribute_name": "タイトル", "attribute_value_mlt": [{"subitem_title": "Hypofractionated Proton Beam Therapy for cT1-2N0M0 Non-small Cell Lung Cancer Patients With Interstitial Lung Disease"}]}, "item_type_id": "8", "owner": "1", "path": ["1"], "permalink_uri": "https://repo.qst.go.jp/records/84787", "pubdate": {"attribute_name": "公開日", "attribute_value": "2021-12-15"}, "publish_date": "2021-12-15", "publish_status": "0", "recid": "84787", "relation": {}, "relation_version_is_last": true, "title": ["Hypofractionated Proton Beam Therapy for cT1-2N0M0 Non-small Cell Lung Cancer Patients With Interstitial Lung Disease"], "weko_shared_id": -1}
Hypofractionated Proton Beam Therapy for cT1-2N0M0 Non-small Cell Lung Cancer Patients With Interstitial Lung Disease
https://repo.qst.go.jp/records/84787
https://repo.qst.go.jp/records/847871c4fa6a3-649f-4437-a657-388c216feef0
Item type | 学術雑誌論文 / Journal Article(1) | |||||
---|---|---|---|---|---|---|
公開日 | 2021-12-15 | |||||
タイトル | ||||||
タイトル | Hypofractionated Proton Beam Therapy for cT1-2N0M0 Non-small Cell Lung Cancer Patients With Interstitial Lung Disease | |||||
言語 | ||||||
言語 | eng | |||||
資源タイプ | ||||||
資源タイプ識別子 | http://purl.org/coar/resource_type/c_6501 | |||||
資源タイプ | journal article | |||||
アクセス権 | ||||||
アクセス権 | metadata only access | |||||
アクセス権URI | http://purl.org/coar/access_right/c_14cb | |||||
著者 |
Saito, Takashi
× Saito, Takashi× Ohnishi, Kayoko× Ishikawa, Hitoshi× Nakamura, Masatoshi× Hoshiai, Sodai× Numajiri, Haruko× Nemoto Murofushi, Keiko× Mizumoto, Masashi× Okumura, Toshiyuki× Sakurai, Hideyuki× Hitoshi, Ishikawa× Hideyuki, Sakurai |
|||||
抄録 | ||||||
内容記述タイプ | Abstract | |||||
内容記述 | Background/Aim: To evaluate the outcomes of proton beam therapy (PBT) for early-stage non-small cell lung cancer (NSCLC) in patients with interstitial lung disease (ILD). Patients and Methods: Between 2002 and 2017, 110 patients receiving hypofractionated PBT for cT1-2N0M0 NSCLC were reviewed. Results: Of the 110 patients, 17 were diagnosed with ILD. The median follow-up period was 37.8 months. No significant difference in the 1-year cumulative rate of grade ≥2 pneumonitis was observed between patients with and those without ILD (17.6% vs. 14.1%, p=0.708). The lung doses were significantly lower in patients with than in those without ILD among patients without grade ≥2 neumonitis. There were no significant differences in overall survival or local recurrence-free rates according to the presence of ILD. Conclusion: PBT appears to be a feasible and effective treatment for cT1-2N0M0 NSCLC in patients with ILD, but the lung dose should be strictly reduced. |
|||||
書誌情報 |
Anticancer research 巻 41, 号 11, p. 5635-5642, 発行日 2021-11 |
|||||
出版者 | ||||||
出版者 | International Institute of Anticancer Research | |||||
ISSN | ||||||
収録物識別子タイプ | ISSN | |||||
収録物識別子 | 0250-7005 | |||||
PubMed番号 | ||||||
識別子タイプ | PMID | |||||
関連識別子 | 34732436 | |||||
DOI | ||||||
識別子タイプ | DOI | |||||
関連識別子 | 10.21873/anticanres.15379 | |||||
関連サイト | ||||||
識別子タイプ | URI | |||||
関連識別子 | https://ar.iiarjournals.org/content/41/11/5635 |